Immune Evasion Uncovered by Virome-Wide Ubiquitin Ligase Discovery
In a new study published inSciencetitled, “Virome-wide ubiquitin ligase discovery reveals diverse mechanisms of immune evasion,”researchers from Harvard Medical School (HMS) have uncovered how viruses hijack cells’ garbage-disposal systems to evade immune attack.
The study appliesORFeome, a tool that broadens the scale by which researchers study viral proteins. The advance proposes to speed basic discoveries in virology, inform the development of new vaccines and treatments to protect against emerging pathogens.
“This library reveals how viruses manipulate human cells on a scale that simply wasn’t possible before,” saidStephen Elledge, PhD, professor of genetics and medicine at Harvard Medical School and senior author of the study. “We believe it changes virology from studying one virus at a time to discovering the common strategies and surprising innovations that viruses have evolved, providing a powerful new foundation for understanding emerging viral threats.”
ORFeome and other ORF libraries are named after open reading frames, DNA sequences that encode proteins. Previous viral ORF libraries from other groups focused on individual viruses or virus families that contained 100 or 200 sequences each. The new ORFeome contains about 13,000 physical DNA sequences, or constructs, that code for about 9,000 proteins from 513 different viruses, including Andes hantavirus, Ebola virus, and Zika virus.
“Most viruses have never been studied in detail, yet evolution has already performed countless experiments for us. This library gives us a way to read the results of those experiments across the viral world,” said Elledge, who is also a Howard Hughes Medical Institute (HHMI) Investigator.
The team attached a genetic barcode to each ORF, allowing researchers to conduct studies of all 13,000 ORFs at once.
“We can insert the sequences into a population of cells, ask questions like which ones cause the cells to grow better or less, and then identify those by their barcodes when the experiment is finished,” saidColin O’Leary, PhD, HMS research fellow and co-author on the study. “It hasn’t been possible before to do genetic screens like this with viral proteins.”
The team will make the ORFeome freely available for the research community. Elledge and colleagues implemented a flexible design to enable application to other model systems and experiments.
The team conducted genetic screens in three cell types, searching for viral proteins that affect cell proliferation, stop cells from presenting antigens to trigger the immune system to attack, or block the effects of interferon. Results uncovered more than 700 viral proteins that contribute to at least one of those actions.
The study opens opportunities to design drugs that hinder viral activity while sparing normal function.
NewsEnzymesGenomicsHost-pathogen interactionInterferonsViral proteinViromePrevious article
Genetic Map Opens Door to Development of New Therapies to Reverse Bone LossNext article
Mung Bean Pan-Genome Study Maps Key Genes for Yield, Nutrition, and Pest ResistanceAlso of Interest
Chronic Interferon Exposure Linked to Immunosuppression in CancerMonoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic MiceWatchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus Expansion'One-Two Punch' Targets Resistance Mechanism in Aggressive Triple-Negative Breast CancerAncient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New AntibioticsMyotisBat Genomes Reveal How They Fight Viruses, Cancer, and Cellular DamageRelated Media
In Conversation with Visionary Geneticist George ChurchBoston's Bioprocessing Buzz:GENReports Live from BPI 2025From Functional Genomics to Cell Therapy: The Role of CRISPR-Based Gene EditingThe Future of Bioinformatics: Scaling Interactive and Computational Workflows with SeqeraGenomics in Snowy Denver: A Video Update from ASHGThanks DC:GENEditors' Final Report from ASHGTop 5ResourcesRecommended For YouPodcast
Touching Base
Touching Base is the dynamic podcast series from the editors ofGEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.Start listening today!
Stay up to date with the lasted episodes of Touching Base bysubscribing to theGENPodcast Newsletter
